| Motoyuki Kohima | Last modified date：2022.09.29 |
Associate Professor /
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University
Department of Clinical Medicine
Faculty of Medical Sciences
Department of Clinical Medicine
Faculty of Medical Sciences
Homepage
https://kyushu-u.pure.elsevier.com/en/persons/motoyuki-kohjima
Reseacher Profiling Tool Kyushu University Pure
Phone
092-642-5282
Fax
092-642-5287
Academic Degree
M.D., Ph.D.
Country of degree conferring institution (Overseas)
Yes Doctor
Field of Specialization
Hepatology
Total Priod of education and research career in the foreign country
03years10months
Research
Research Interests
- Physiological analysis of microstructure in NASH hepatic tissue.
keyword : NASH, microstructure
2019.04～2025.03. - Classification and evaluation of acute liver injury patients
keyword : Acute liver injury
2016.04～2023.03. - Evaluation of intrahepatic hypoxia using PBMC
keyword : Acute hepatic failure, Tissue hypoxia, PBMC
2016.04～2020.03. - Evaluation and treatment response of intrahepatic microcirculatory disorder in mouse acute liver injury model
keyword : Acute liver injury, Microcirculatory disorder
2016.04～2022.03. - Differentian body composition and fat distribution in clinical condition and disease background
keyword : body composition, fat distribution
2016.04～2023.03. - Resolution of the mechanism and organ correlation for liver steatosis
keyword : liver steatosis, organ correlation
2016.04～2022.03. - Metabolic shift of glucose and fat and involvement of glucose and fat metabolism in the development of hepatocellular carcinoma
keyword : hepatocellular carcinoma, glucose metabolism, lipid metabolism
2016.04～2023.03. - Control for pathogenesis of hepatocellular carcinoma in NASH woman patients post menopause
keyword : post menopause, NASH, hepatocellular carcinoma
2016.04～2023.03.
- The clinical study will investigate the efficacy and safety of combination therapy with daclatasvir and asunaprevir, new therapeutic drugs, and predictors for treatment effect. These predictors include treatment factors on the host and viral cells in patients with genotype 1 chronic hepatitis C and compensated type C cirrhosis. The information gathered from this study is expected to aid in the prediction and understanding of the effect of new drug treatments on patients. It will also to lead to the establishment of tailor-made future drug treatments .
Papers
Educational
Unauthorized reprint of the contents of this database is prohibited.